ENGLISH

The role of interleukin-2 in the treatment of cancer patients

By ChB , MB , MRCP (eds.) , John Wagstaff (auth.) , John Wagstaff MD

Book information

Publisher
Springer Netherlands
Year
1993
ISBN
978-94-010-4769-2, 978-94-011-1753-1
DOI
10.1007/978-94-011-1753-1
Language
english
Format
PDF
Filesize
4 MB (4528060 bytes)
Edition
1
Pages
191\191
Time added
2013-12-12 02:00:00
Oncology; Immunology

Description

Recombinant human interleukin-2 became available for clinical use in the mid 1980s. Recent years have seen an enormous amount of clinical research with this cytokine and interleukin-2 has now been registered for use in a number of European countries for the treatment of metastatic renal cell carcinoma. This book is designed to provide the clinical oncologist wishing to use interleukin-2 with a basic background concerning the biology of the agent, a discussion concerning practical aspects, of its clinical use including management of toxicity and an overview of the clinical results together with a description of how this internesting cytokine might be developed in the future.

Similar books